Aram Boada

1.2k total citations
68 papers, 515 citations indexed

About

Aram Boada is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Aram Boada has authored 68 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 27 papers in Molecular Biology and 25 papers in Epidemiology. Recurrent topics in Aram Boada's work include Cutaneous Melanoma Detection and Management (29 papers), Melanoma and MAPK Pathways (21 papers) and Nonmelanoma Skin Cancer Studies (17 papers). Aram Boada is often cited by papers focused on Cutaneous Melanoma Detection and Management (29 papers), Melanoma and MAPK Pathways (21 papers) and Nonmelanoma Skin Cancer Studies (17 papers). Aram Boada collaborates with scholars based in Spain, Italy and Austria. Aram Boada's co-authors include Carlos Ferrándiz, María Teresa Fernández‐Figueras, Isabel Bielsa, J.M. Carrascosa, A. Tejera‐Vaquerizo, J.M. Carrascosa, Cristina Carrera, María Teresa Cabero Morán, Sabela Paradela and Enric Carcereny and has published in prestigious journals such as Journal of Investigative Dermatology, Journal of the American Academy of Dermatology and European Journal of Cancer.

In The Last Decade

Aram Boada

60 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aram Boada Spain 13 237 171 131 122 116 68 515
Julián Conejo‐Mir Spain 12 179 0.8× 172 1.0× 116 0.9× 75 0.6× 42 0.4× 84 527
Anna Colagrande Italy 12 181 0.8× 88 0.5× 60 0.5× 69 0.6× 77 0.7× 60 425
Louise Fearfield United Kingdom 12 208 0.9× 109 0.6× 144 1.1× 147 1.2× 51 0.4× 32 551
Pietro Sollena Italy 11 218 0.9× 174 1.0× 177 1.4× 66 0.5× 56 0.5× 32 451
François Lagacé Canada 14 184 0.8× 161 0.9× 130 1.0× 65 0.5× 52 0.4× 37 455
Grażyna Kamińska‐Winciorek Poland 10 214 0.9× 191 1.1× 146 1.1× 64 0.5× 49 0.4× 89 418
L. Ríos‐Buceta Spain 13 152 0.6× 179 1.0× 170 1.3× 80 0.7× 29 0.3× 48 447
Razieh Soltani‐Arabshahi Iran 13 80 0.3× 261 1.5× 99 0.8× 75 0.6× 303 2.6× 19 679
Victoria Williams United States 11 81 0.3× 106 0.6× 83 0.6× 50 0.4× 59 0.5× 30 358
Seaver L. Soon United States 12 215 0.9× 379 2.2× 228 1.7× 102 0.8× 55 0.5× 28 629

Countries citing papers authored by Aram Boada

Since Specialization
Citations

This map shows the geographic impact of Aram Boada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aram Boada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aram Boada more than expected).

Fields of papers citing papers by Aram Boada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aram Boada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aram Boada. The network helps show where Aram Boada may publish in the future.

Co-authorship network of co-authors of Aram Boada

This figure shows the co-authorship network connecting the top 25 collaborators of Aram Boada. A scholar is included among the top collaborators of Aram Boada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aram Boada. Aram Boada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moreno‐Ramírez, D., Almudena Fernández, F.M. Almazán-Fernández, et al.. (2025). Conservative lymph node surgery for patients with stage III melanoma: a prospective longitudinal cohort. The Oncologist. 30(9).
2.
Sun, Chen, Aram Boada, Anna Martínez‐Cardús, et al.. (2024). Targeted therapy or immunotherapy in BRAF-mutated metastatic melanoma: a Spanish center’s decade of experience. Frontiers in Oncology. 14. 1322116–1322116. 2 indexed citations
3.
Sun, Chen, et al.. (2023). Immunotherapy Resumption/Rechallenge in Melanoma Patients after Toxicity: Do We Have Another Chance?. Pharmaceutics. 15(3). 823–823. 1 indexed citations
4.
Carrascosa, J.M., et al.. (2022). Epidemia de escabiosis: los nuevos retos de una enfermedad ancestral. Actas Dermo-Sifiliográficas. 114(2). 132–140. 6 indexed citations
5.
Barreiro, Alicia, Sebastián Podlipnik, Cristina Carrera, et al.. (2021). Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study. European Journal of Cancer. 145. 29–37. 12 indexed citations
6.
Boada, Aram, et al.. (2021). Association between melanoma thickness and clinical and demographic characteristics. European Journal of Dermatology. 31(4). 514–520. 4 indexed citations
7.
Boada, Aram, A. Tejera‐Vaquerizo, Simone Ribero, et al.. (2020). Age as a prognostic factor in thick and ultrathick melanomas without lymph node metastasis. Journal of the European Academy of Dermatology and Venereology. 34(9). e513–e517. 5 indexed citations
8.
Botella‐Estrada, Rafael, Aram Boada, María Teresa Fernández‐Figueras, et al.. (2020). Guía de práctica clínica de melanoma de la Academia Española de Dermatología y Venereología. Actas Dermo-Sifiliográficas. 112(2). 142–152. 6 indexed citations
9.
Tejera‐Vaquerizo, A., Aram Boada, & Eduardo Nagore. (2020). ¿Por qué no disminuye la mortalidad por melanoma cutáneo?. Actas Dermo-Sifiliográficas. 111(6). 450–452. 4 indexed citations
10.
Fernández, Gema, et al.. (2019). Epidemiology of dermatophytic infections between 2008 and 2017 in Barcelona, Spain. Enfermedades Infecciosas y Microbiología Clínica. 37(10). 642–647. 14 indexed citations
11.
Boada, Aram, Cristina Carrera, Sònia Segura, et al.. (2018). Cutaneous toxicities of new treatments for melanoma. Clinical & Translational Oncology. 20(11). 1373–1384. 25 indexed citations
12.
Moreno‐Ramírez, D., Aram Boada, Lara Ferrándiz, et al.. (2018). Disección ganglionar en el paciente con melanoma y metástasis en el ganglio centinela: propuesta de decisión basada en la evidencia actual. Actas Dermo-Sifiliográficas. 109(5). 390–398. 4 indexed citations
13.
Boada, Aram, et al.. (2018). Mycophenolate mofetil-induced mouth ulcers in a kidney transplant patient: Case report and literature review. Nefrología. 39(1). 80–83. 7 indexed citations
14.
Garcia, Juan, et al.. (2017). Osimertinib-related skin and mucosal adverse events. Cancer Treatment and Research Communications. 12. 53–55. 1 indexed citations
15.
Cueva, P. de la, L.J. del Pozo, D. Moreno‐Ramírez, et al.. (2016). Análisis de coste-efectividad y coste-utilidad de ingenol mebutato versus diclofenaco 3% e imiquimod 5% en el tratamiento de la queratosis actínica en España. Actas Dermo-Sifiliográficas. 107(6). 498–508. 7 indexed citations
16.
Cueva, P. de la, et al.. (2015). Cost-Utility Analysis of Ingenol Mebutate Versus Imiquimod 5% for Actinic Keratosis Treatment In Spain. Value in Health. 18(7). A423–A423. 2 indexed citations
17.
Molina‐Ruiz, A.M., et al.. (2014). La página de Facebook de Actas Dermo-Sifiliográficas. Actas Dermo-Sifiliográficas. 105(7). 635–638. 3 indexed citations
18.
Molina‐Ruiz, A.M., et al.. (2013). Actas 2.0: el salto de Actas DermoSifiliográficas a las redes sociales. Actas Dermo-Sifiliográficas. 104(9). 735–737. 3 indexed citations
19.
Carretero-Iglesia, Laura, Aram Boada, Roger Colobrán, et al.. (2011). CCL4L Polymorphisms and CCL4/CCL4L Serum Levels Are Associated with Psoriasis Severity. Journal of Investigative Dermatology. 131(9). 1830–1837. 28 indexed citations
20.
Boada, Aram, Isabel Bielsa, María Teresa Fernández‐Figueras, & Carlos Ferrándiz. (2010). Perniosis: Clinical and Histopathological Analysis. American Journal of Dermatopathology. 32(1). 19–23. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julián Conejo‐Mir Breakdown of academic impact, for papers by Anna Colagrande Breakdown of academic impact, for papers by Louise Fearfield Breakdown of academic impact, for papers by Pietro Sollena Breakdown of academic impact, for papers by François Lagacé Breakdown of academic impact, for papers by Grażyna Kamińska‐Winciorek Breakdown of academic impact, for papers by L. Ríos‐Buceta Breakdown of academic impact, for papers by Razieh Soltani‐Arabshahi Breakdown of academic impact, for papers by Victoria Williams Breakdown of academic impact, for papers by Seaver L. Soon
Rankless by CCL
2026